NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-50 Cr | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-50 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹41 Cr |
How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-50 Cr | Negative | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹12 Cr | -58.80 | |
| Mar2022 | ₹30 Cr | -27.12 | |
| Mar2021 | ₹41 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,744.4 Cr | -0% | -13.1% | -29.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0% |
-13.1% |
-29.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses